 | • レポートコード：MRC2-11QY04389 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は前立腺がんスクリーニングのグローバル市場について調査・分析したレポートです。種類別（身体検査、臨床検査、画像検査、グリーソンスコア、TNMスコア、遺伝子検査、直腸指診、生検）市場規模、用途別（病院、診療所、研究所、がん研究所、診断センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別前立腺がんスクリーニングの競争状況、市場シェア ・世界の前立腺がんスクリーニング市場：種類別市場規模 2015年-2020年（身体検査、臨床検査、画像検査、グリーソンスコア、TNMスコア、遺伝子検査、直腸指診、生検） ・世界の前立腺がんスクリーニング市場：種類別市場規模予測 2021年-2026年（身体検査、臨床検査、画像検査、グリーソンスコア、TNMスコア、遺伝子検査、直腸指診、生検） ・世界の前立腺がんスクリーニング市場：用途別市場規模 2015年-2020年（病院、診療所、研究所、がん研究所、診断センター、その他） ・世界の前立腺がんスクリーニング市場：用途別市場規模予測 2021年-2026年（病院、診療所、研究所、がん研究所、診断センター、その他） ・北米の前立腺がんスクリーニング市場分析：米国、カナダ ・ヨーロッパの前立腺がんスクリーニング市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの前立腺がんスクリーニング市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の前立腺がんスクリーニング市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの前立腺がんスクリーニング市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott Laboratories、Almac、Bayer、Beckman Coulter、BioméRieux、Genomic Health、Mayo Clinic、Mdxhealth、Roche Diagnostics、Rosetta Genomics、Thermo Fisher Scientific、Hologic、Myriad Genetics ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Prostate cancer screening is the screening process used to detect undiagnosed prostate cancer in those without signs or symptoms.
The digital rectal examination is one screening tool during which the prostate is assessed manually through the wall of the rectum. The second screening tool is the measurement of prostate-specific antigen in the blood.
Market Analysis and Insights: Global Prostate Cancer Screening Market
The global Prostate Cancer Screening market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Prostate Cancer Screening Scope and Market Size
Prostate Cancer Screening market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Prostate Cancer Screening market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott Laboratories
Almac
Bayer
Beckman Coulter
BioméRieux
Genomic Health
Mayo Clinic
Mdxhealth
Roche Diagnostics
Rosetta Genomics
Thermo Fisher Scientific
Hologic
Myriad Genetics
Market segment by Type, the product can be split into
Physical Exam
Laboratory Tests
Imaging Tests
Gleason Score
TNM Score
Genetic Tests
Digital Rectal Exam
Biopsy
Market segment by Application, split into
Hospitals
Clinics
Research Labs
Cancer Institutes
Diagnostic Centers
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Prostate Cancer Screening Revenue
1.4 Market by Type
1.4.1 Global Prostate Cancer Screening Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Physical Exam
1.4.3 Laboratory Tests
1.4.4 Imaging Tests
1.4.5 Gleason Score
1.4.6 TNM Score
1.4.7 Genetic Tests
1.4.8 Digital Rectal Exam
1.4.9 Biopsy
1.5 Market by Application
1.5.1 Global Prostate Cancer Screening Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Research Labs
1.5.5 Cancer Institutes
1.5.6 Diagnostic Centers
1.5.7 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Prostate Cancer Screening Market Perspective (2015-2026)
2.2 Global Prostate Cancer Screening Growth Trends by Regions
2.2.1 Prostate Cancer Screening Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Prostate Cancer Screening Historic Market Share by Regions (2015-2020)
2.2.3 Prostate Cancer Screening Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Prostate Cancer Screening Market Growth Strategy
2.3.6 Primary Interviews with Key Prostate Cancer Screening Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Prostate Cancer Screening Players by Market Size
3.1.1 Global Top Prostate Cancer Screening Players by Revenue (2015-2020)
3.1.2 Global Prostate Cancer Screening Revenue Market Share by Players (2015-2020)
3.1.3 Global Prostate Cancer Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Prostate Cancer Screening Market Concentration Ratio
3.2.1 Global Prostate Cancer Screening Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Prostate Cancer Screening Revenue in 2019
3.3 Prostate Cancer Screening Key Players Head office and Area Served
3.4 Key Players Prostate Cancer Screening Product Solution and Service
3.5 Date of Enter into Prostate Cancer Screening Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Prostate Cancer Screening Historic Market Size by Type (2015-2020)
4.2 Global Prostate Cancer Screening Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Prostate Cancer Screening Market Size by Application (2015-2020)
5.2 Global Prostate Cancer Screening Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Prostate Cancer Screening Market Size (2015-2020)
6.2 Prostate Cancer Screening Key Players in North America (2019-2020)
6.3 North America Prostate Cancer Screening Market Size by Type (2015-2020)
6.4 North America Prostate Cancer Screening Market Size by Application (2015-2020)
7 Europe
7.1 Europe Prostate Cancer Screening Market Size (2015-2020)
7.2 Prostate Cancer Screening Key Players in Europe (2019-2020)
7.3 Europe Prostate Cancer Screening Market Size by Type (2015-2020)
7.4 Europe Prostate Cancer Screening Market Size by Application (2015-2020)
8 China
8.1 China Prostate Cancer Screening Market Size (2015-2020)
8.2 Prostate Cancer Screening Key Players in China (2019-2020)
8.3 China Prostate Cancer Screening Market Size by Type (2015-2020)
8.4 China Prostate Cancer Screening Market Size by Application (2015-2020)
9 Japan
9.1 Japan Prostate Cancer Screening Market Size (2015-2020)
9.2 Prostate Cancer Screening Key Players in Japan (2019-2020)
9.3 Japan Prostate Cancer Screening Market Size by Type (2015-2020)
9.4 Japan Prostate Cancer Screening Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Prostate Cancer Screening Market Size (2015-2020)
10.2 Prostate Cancer Screening Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Prostate Cancer Screening Market Size by Type (2015-2020)
10.4 Southeast Asia Prostate Cancer Screening Market Size by Application (2015-2020)
11 India
11.1 India Prostate Cancer Screening Market Size (2015-2020)
11.2 Prostate Cancer Screening Key Players in India (2019-2020)
11.3 India Prostate Cancer Screening Market Size by Type (2015-2020)
11.4 India Prostate Cancer Screening Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Prostate Cancer Screening Market Size (2015-2020)
12.2 Prostate Cancer Screening Key Players in Central & South America (2019-2020)
12.3 Central & South America Prostate Cancer Screening Market Size by Type (2015-2020)
12.4 Central & South America Prostate Cancer Screening Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Details
13.1.2 Abbott Laboratories Business Overview
13.1.3 Abbott Laboratories Prostate Cancer Screening Introduction
13.1.4 Abbott Laboratories Revenue in Prostate Cancer Screening Business (2015-2020))
13.1.5 Abbott Laboratories Recent Development
13.2 Almac
13.2.1 Almac Company Details
13.2.2 Almac Business Overview
13.2.3 Almac Prostate Cancer Screening Introduction
13.2.4 Almac Revenue in Prostate Cancer Screening Business (2015-2020)
13.2.5 Almac Recent Development
13.3 Bayer
13.3.1 Bayer Company Details
13.3.2 Bayer Business Overview
13.3.3 Bayer Prostate Cancer Screening Introduction
13.3.4 Bayer Revenue in Prostate Cancer Screening Business (2015-2020)
13.3.5 Bayer Recent Development
13.4 Beckman Coulter
13.4.1 Beckman Coulter Company Details
13.4.2 Beckman Coulter Business Overview
13.4.3 Beckman Coulter Prostate Cancer Screening Introduction
13.4.4 Beckman Coulter Revenue in Prostate Cancer Screening Business (2015-2020)
13.4.5 Beckman Coulter Recent Development
13.5 BioméRieux
13.5.1 BioméRieux Company Details
13.5.2 BioméRieux Business Overview
13.5.3 BioméRieux Prostate Cancer Screening Introduction
13.5.4 BioméRieux Revenue in Prostate Cancer Screening Business (2015-2020)
13.5.5 BioméRieux Recent Development
13.6 Genomic Health
13.6.1 Genomic Health Company Details
13.6.2 Genomic Health Business Overview
13.6.3 Genomic Health Prostate Cancer Screening Introduction
13.6.4 Genomic Health Revenue in Prostate Cancer Screening Business (2015-2020)
13.6.5 Genomic Health Recent Development
13.7 Mayo Clinic
13.7.1 Mayo Clinic Company Details
13.7.2 Mayo Clinic Business Overview
13.7.3 Mayo Clinic Prostate Cancer Screening Introduction
13.7.4 Mayo Clinic Revenue in Prostate Cancer Screening Business (2015-2020)
13.7.5 Mayo Clinic Recent Development
13.8 Mdxhealth
13.8.1 Mdxhealth Company Details
13.8.2 Mdxhealth Business Overview
13.8.3 Mdxhealth Prostate Cancer Screening Introduction
13.8.4 Mdxhealth Revenue in Prostate Cancer Screening Business (2015-2020)
13.8.5 Mdxhealth Recent Development
13.9 Roche Diagnostics
13.9.1 Roche Diagnostics Company Details
13.9.2 Roche Diagnostics Business Overview
13.9.3 Roche Diagnostics Prostate Cancer Screening Introduction
13.9.4 Roche Diagnostics Revenue in Prostate Cancer Screening Business (2015-2020)
13.9.5 Roche Diagnostics Recent Development
13.10 Rosetta Genomics
13.10.1 Rosetta Genomics Company Details
13.10.2 Rosetta Genomics Business Overview
13.10.3 Rosetta Genomics Prostate Cancer Screening Introduction
13.10.4 Rosetta Genomics Revenue in Prostate Cancer Screening Business (2015-2020)
13.10.5 Rosetta Genomics Recent Development
13.11 Thermo Fisher Scientific
10.11.1 Thermo Fisher Scientific Company Details
10.11.2 Thermo Fisher Scientific Business Overview
10.11.3 Thermo Fisher Scientific Prostate Cancer Screening Introduction
10.11.4 Thermo Fisher Scientific Revenue in Prostate Cancer Screening Business (2015-2020)
10.11.5 Thermo Fisher Scientific Recent Development
13.12 Hologic
10.12.1 Hologic Company Details
10.12.2 Hologic Business Overview
10.12.3 Hologic Prostate Cancer Screening Introduction
10.12.4 Hologic Revenue in Prostate Cancer Screening Business (2015-2020)
10.12.5 Hologic Recent Development
13.13 Myriad Genetics
10.13.1 Myriad Genetics Company Details
10.13.2 Myriad Genetics Business Overview
10.13.3 Myriad Genetics Prostate Cancer Screening Introduction
10.13.4 Myriad Genetics Revenue in Prostate Cancer Screening Business (2015-2020)
10.13.5 Myriad Genetics Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Prostate Cancer Screening Key Market Segments
Table 2. Key Players Covered: Ranking by Prostate Cancer Screening Revenue
Table 3. Ranking of Global Top Prostate Cancer Screening Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Prostate Cancer Screening Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Physical Exam
Table 6. Key Players of Laboratory Tests
Table 7. Key Players of Imaging Tests
Table 8. Key Players of Gleason Score
Table 9. Key Players of TNM Score
Table 10. Key Players of Genetic Tests
Table 11. Key Players of Digital Rectal Exam
Table 12. Key Players of Biopsy
Table 13. Global Prostate Cancer Screening Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Prostate Cancer Screening Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Prostate Cancer Screening Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Prostate Cancer Screening Market Share by Regions (2015-2020)
Table 17. Global Prostate Cancer Screening Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Prostate Cancer Screening Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Prostate Cancer Screening Market Growth Strategy
Table 23. Main Points Interviewed from Key Prostate Cancer Screening Players
Table 24. Global Prostate Cancer Screening Revenue by Players (2015-2020) (Million US$)
Table 25. Global Prostate Cancer Screening Market Share by Players (2015-2020)
Table 26. Global Top Prostate Cancer Screening Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Screening as of 2019)
Table 27. Global Prostate Cancer Screening by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Prostate Cancer Screening Product Solution and Service
Table 30. Date of Enter into Prostate Cancer Screening Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Prostate Cancer Screening Market Size by Type (2015-2020) (Million US$)
Table 33. Global Prostate Cancer Screening Market Size Share by Type (2015-2020)
Table 34. Global Prostate Cancer Screening Revenue Market Share by Type (2021-2026)
Table 35. Global Prostate Cancer Screening Market Size Share by Application (2015-2020)
Table 36. Global Prostate Cancer Screening Market Size by Application (2015-2020) (Million US$)
Table 37. Global Prostate Cancer Screening Market Size Share by Application (2021-2026)
Table 38. North America Key Players Prostate Cancer Screening Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Prostate Cancer Screening Market Share (2019-2020)
Table 40. North America Prostate Cancer Screening Market Size by Type (2015-2020) (Million US$)
Table 41. North America Prostate Cancer Screening Market Share by Type (2015-2020)
Table 42. North America Prostate Cancer Screening Market Size by Application (2015-2020) (Million US$)
Table 43. North America Prostate Cancer Screening Market Share by Application (2015-2020)
Table 44. Europe Key Players Prostate Cancer Screening Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Prostate Cancer Screening Market Share (2019-2020)
Table 46. Europe Prostate Cancer Screening Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Prostate Cancer Screening Market Share by Type (2015-2020)
Table 48. Europe Prostate Cancer Screening Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Prostate Cancer Screening Market Share by Application (2015-2020)
Table 50. China Key Players Prostate Cancer Screening Revenue (2019-2020) (Million US$)
Table 51. China Key Players Prostate Cancer Screening Market Share (2019-2020)
Table 52. China Prostate Cancer Screening Market Size by Type (2015-2020) (Million US$)
Table 53. China Prostate Cancer Screening Market Share by Type (2015-2020)
Table 54. China Prostate Cancer Screening Market Size by Application (2015-2020) (Million US$)
Table 55. China Prostate Cancer Screening Market Share by Application (2015-2020)
Table 56. Japan Key Players Prostate Cancer Screening Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Prostate Cancer Screening Market Share (2019-2020)
Table 58. Japan Prostate Cancer Screening Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Prostate Cancer Screening Market Share by Type (2015-2020)
Table 60. Japan Prostate Cancer Screening Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Prostate Cancer Screening Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Prostate Cancer Screening Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Prostate Cancer Screening Market Share (2019-2020)
Table 64. Southeast Asia Prostate Cancer Screening Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Prostate Cancer Screening Market Share by Type (2015-2020)
Table 66. Southeast Asia Prostate Cancer Screening Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Prostate Cancer Screening Market Share by Application (2015-2020)
Table 68. India Key Players Prostate Cancer Screening Revenue (2019-2020) (Million US$)
Table 69. India Key Players Prostate Cancer Screening Market Share (2019-2020)
Table 70. India Prostate Cancer Screening Market Size by Type (2015-2020) (Million US$)
Table 71. India Prostate Cancer Screening Market Share by Type (2015-2020)
Table 72. India Prostate Cancer Screening Market Size by Application (2015-2020) (Million US$)
Table 73. India Prostate Cancer Screening Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Prostate Cancer Screening Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Prostate Cancer Screening Market Share (2019-2020)
Table 76. Central & South America Prostate Cancer Screening Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Prostate Cancer Screening Market Share by Type (2015-2020)
Table 78. Central & South America Prostate Cancer Screening Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Prostate Cancer Screening Market Share by Application (2015-2020)
Table 80. Abbott Laboratories Company Details
Table 81. Abbott Laboratories Business Overview
Table 82. Abbott Laboratories Product
Table 83. Abbott Laboratories Revenue in Prostate Cancer Screening Business (2015-2020) (Million US$)
Table 84. Abbott Laboratories Recent Development
Table 85. Almac Company Details
Table 86. Almac Business Overview
Table 87. Almac Product
Table 88. Almac Revenue in Prostate Cancer Screening Business (2015-2020) (Million US$)
Table 89. Almac Recent Development
Table 90. Bayer Company Details
Table 91. Bayer Business Overview
Table 92. Bayer Product
Table 93. Bayer Revenue in Prostate Cancer Screening Business (2015-2020) (Million US$)
Table 94. Bayer Recent Development
Table 95. Beckman Coulter Company Details
Table 96. Beckman Coulter Business Overview
Table 97. Beckman Coulter Product
Table 98. Beckman Coulter Revenue in Prostate Cancer Screening Business (2015-2020) (Million US$)
Table 99. Beckman Coulter Recent Development
Table 100. BioméRieux Company Details
Table 101. BioméRieux Business Overview
Table 102. BioméRieux Product
Table 103. BioméRieux Revenue in Prostate Cancer Screening Business (2015-2020) (Million US$)
Table 104. BioméRieux Recent Development
Table 105. Genomic Health Company Details
Table 106. Genomic Health Business Overview
Table 107. Genomic Health Product
Table 108. Genomic Health Revenue in Prostate Cancer Screening Business (2015-2020) (Million US$)
Table 109. Genomic Health Recent Development
Table 110. Mayo Clinic Company Details
Table 111. Mayo Clinic Business Overview
Table 112. Mayo Clinic Product
Table 113. Mayo Clinic Revenue in Prostate Cancer Screening Business (2015-2020) (Million US$)
Table 114. Mayo Clinic Recent Development
Table 115. Mdxhealth Business Overview
Table 116. Mdxhealth Product
Table 117. Mdxhealth Company Details
Table 118. Mdxhealth Revenue in Prostate Cancer Screening Business (2015-2020) (Million US$)
Table 119. Mdxhealth Recent Development
Table 120. Roche Diagnostics Company Details
Table 121. Roche Diagnostics Business Overview
Table 122. Roche Diagnostics Product
Table 123. Roche Diagnostics Revenue in Prostate Cancer Screening Business (2015-2020) (Million US$)
Table 124. Roche Diagnostics Recent Development
Table 125. Rosetta Genomics Company Details
Table 126. Rosetta Genomics Business Overview
Table 127. Rosetta Genomics Product
Table 128. Rosetta Genomics Revenue in Prostate Cancer Screening Business (2015-2020) (Million US$)
Table 129. Rosetta Genomics Recent Development
Table 130. Thermo Fisher Scientific Company Details
Table 131. Thermo Fisher Scientific Business Overview
Table 132. Thermo Fisher Scientific Product
Table 133. Thermo Fisher Scientific Revenue in Prostate Cancer Screening Business (2015-2020) (Million US$)
Table 134. Thermo Fisher Scientific Recent Development
Table 135. Hologic Company Details
Table 136. Hologic Business Overview
Table 137. Hologic Product
Table 138. Hologic Revenue in Prostate Cancer Screening Business (2015-2020) (Million US$)
Table 139. Hologic Recent Development
Table 140. Myriad Genetics Company Details
Table 141. Myriad Genetics Business Overview
Table 142. Myriad Genetics Product
Table 143. Myriad Genetics Revenue in Prostate Cancer Screening Business (2015-2020) (Million US$)
Table 144. Myriad Genetics Recent Development
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prostate Cancer Screening Market Share by Type: 2020 VS 2026
Figure 2. Physical Exam Features
Figure 3. Laboratory Tests Features
Figure 4. Imaging Tests Features
Figure 5. Gleason Score Features
Figure 6. TNM Score Features
Figure 7. Genetic Tests Features
Figure 8. Digital Rectal Exam Features
Figure 9. Biopsy Features
Figure 10. Global Prostate Cancer Screening Market Share by Application: 2020 VS 2026
Figure 11. Hospitals Case Studies
Figure 12. Clinics Case Studies
Figure 13. Research Labs Case Studies
Figure 14. Cancer Institutes Case Studies
Figure 15. Diagnostic Centers Case Studies
Figure 16. Others Case Studies
Figure 17. Prostate Cancer Screening Report Years Considered
Figure 18. Global Prostate Cancer Screening Market Size YoY Growth 2015-2026 (US$ Million)
Figure 19. Global Prostate Cancer Screening Market Share by Regions: 2020 VS 2026
Figure 20. Global Prostate Cancer Screening Market Share by Regions (2021-2026)
Figure 21. Porter's Five Forces Analysis
Figure 22. Global Prostate Cancer Screening Market Share by Players in 2019
Figure 23. Global Top Prostate Cancer Screening Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prostate Cancer Screening as of 2019
Figure 24. The Top 10 and 5 Players Market Share by Prostate Cancer Screening Revenue in 2019
Figure 25. North America Prostate Cancer Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Europe Prostate Cancer Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. China Prostate Cancer Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Japan Prostate Cancer Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Southeast Asia Prostate Cancer Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. India Prostate Cancer Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 31. Central & South America Prostate Cancer Screening Market Size YoY Growth (2015-2020) (Million US$)
Figure 32. Bottom-up and Top-down Approaches for This Report
Figure 33. Data Triangulation
Figure 34. Key Executives Interviewed
乳癌スクリーニング検査の世界市場（～2026年） Breast cancer is usually a form of tumor that can be visualized through x-ray or felt as a lump. The cancer can be either benign which results in the abnormal growth in the breast area or metastatic that can invade the distant areas of the body. Breast cancer screening is conducted to detect the sig…- 子宮頸がんスクリーニングの世界市場（～2026年） Cervical screening is the process of recognizing and expelling abnormal tissue or cells in the cervix before precancerous cervical lesions or cervical malignancy develops. Continuous growth of cancer‘s impact on Public Health is the primary factor that drives the Cervical Cancer Screening Market. Th…
- 前立腺がんの世界市場（～2026年） Prostate cancer is cancer that occurs in the prostate. Market Analysis and Insights: Global Prostate Cancer Market The global Prostate Cancer market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Prostate Cancer Scope and Ma…
- ホルモン抵抗性前立腺がんの世界市場（～2026年） Hormone Refractory Prostate Cancer (HRPCA) or Castrate-Resistant Prostate Cancer (CRPC), a type of prostate cancer that typically recurs after having hormonal therapy, is now under the spotlight in prostate cancer market. Due to the high unmet clinical need associated with limited survival periods, …
- 前立腺がん診断・治療の世界市場（～2026年） Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. The market is growing impressively due to rise in incidence and prevalence rate of prostate cancer, robust R&D exploration and rising investment in grants and investment across the globe. Market An…